After the FDA authorized Johnson & Johnson’s COVID-19 vaccine for emergency use in February 2021, Kadlec pressured the pharmaceutical giant to sign a $480 million contract with the El-Hibris to perform the manufacturing of J&J’s COVID-19 jabs. Forbes headlined: “Little-Known Publicly Traded Company Given Massive Deal to Manufacture One-Shot Covid-19 Vaccine.”112
